is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Detailed information on GlaxoSmithKline Plc required for business and competitor intelligence needs
A study of the major internal and external factors affecting GlaxoSmithKline Plc in the form of a SWOT analysis
An in-depth view of the business model of GlaxoSmithKline Plc including a breakdown and examination of key business segments
Intelligence on GlaxoSmithKline Plc’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about GlaxoSmithKline Plc, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
GlaxoSmithKline (GSK or 'the company') is a leading global provider of pharmaceutical and consumer health-related products. The company primarily operates in the US, Europe, Asia-Pacific. GSK is headquartered in Brentford, the UK, and employed 99,451 people as on December 31, 2013. The company recorded revenues of £26,505 million (approximately $41,427.3 million) during the financial year ended December 2013 (FY2013), an increase of 0.3% over FY2012. The operating profit of the company was £7,028 million (approximately $10,984.8 million) during FY2013, a decrease of 3.7% compared with FY2012. The net profit was £5,436 million (approximately $8,496.5 million) in FY2013, an increase of 20.8% over FY2012. In April 2014, GSK entered into an agreement with Novartis to acquire Novartis’s Vaccines business (excluding flu), to create a new consumer healthcare business by combining its consumer healthcare business with Novartis’s over the counter products and to divest its portfolio of oncology products to Novartis.
Reasons to Purchase:
Gain understanding of GlaxoSmithKline Plc and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess GlaxoSmithKline Plc as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on GlaxoSmithKline Plc’s business structure, strategy and prospects